Martin Miner

ORCID: 0000-0001-6813-9242
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hormonal and reproductive studies
  • Sexual function and dysfunction studies
  • Urinary Bladder and Prostate Research
  • Pharmacology and Obesity Treatment
  • Sexual Differentiation and Disorders
  • Cardiovascular Health and Disease Prevention
  • Prostate Cancer Diagnosis and Treatment
  • Cerebrovascular and Carotid Artery Diseases
  • Sexuality, Behavior, and Technology
  • COVID-19 diagnosis using AI
  • Cardiac Imaging and Diagnostics
  • Prostate Cancer Treatment and Research
  • Muscle metabolism and nutrition
  • Pelvic floor disorders treatments
  • Hypothalamic control of reproductive hormones
  • Cardiovascular Disease and Adiposity
  • Radiomics and Machine Learning in Medical Imaging
  • Genital Health and Disease
  • Stress Responses and Cortisol
  • Pharmacological Effects and Assays
  • Cardiovascular Function and Risk Factors
  • Blood Pressure and Hypertension Studies
  • Lung Cancer Diagnosis and Treatment
  • Menopause: Health Impacts and Treatments
  • Sperm and Testicular Function

Miriam Hospital
2016-2025

Providence College
2016-2025

Brown University
2015-2024

Visvesvaraya National Institute of Technology
2019-2020

Memorial Medical Center
2020

Universidade Estadual de Feira de Santana
2020

New York Proton Center
2020

Indraprastha Apollo Hospitals
2019

Men's Health Boston
2016-2019

American Urological Association
2015-2018

There has been a marked increase in testosterone prescriptions the past decade resulting growing need to give practicing clinicians proper guidance on evaluation and management of deficient patient.A systematic review utilized research from Mayo Clinic Evidence Based Practice Center additional supplementation by authors. Evidence-based statements were based body evidence strength Grade A, B, or C designated as Strong, Moderate, Conditional Recommendations with presented form Clinical...

10.1016/j.juro.2018.03.115 article EN The Journal of Urology 2018-03-28

The purpose of this guideline is to provide a clinical framework for the diagnosis and treatment Peyronie's disease.A systematic review literature using PubMed®, EMBASE® Cochrane databases (search dates 1/1/1965 1/26/15) was conducted identify peer-reviewed publications relevant PD. yielded an evidence base 303 articles after application inclusion/exclusion criteria.The used create statements regarding When sufficient existed, body particular assigned strength rating A (high quality...

10.1016/j.juro.2015.05.098 article EN The Journal of Urology 2015-06-12
Veda N. Giri Karen E. Knudsen William Kevin Kelly Heather H. Cheng Kathleen A. Cooney and 87 more Michael S. Cookson William L. Dahut Scott M. Weissman Howard R. Soule Daniel P. Petrylak Adam P. Dicker Saud H. AlDubayan Amanda E. Toland Colin C. Pritchard Curtis A. Pettaway Mary B. Daly James L. Mohler J. Kellogg Parsons Peter R. Carroll Robert Pilarski Amie Blanco Ashley Woodson Alanna Kulchak Rahm Mary-Ellen Taplin Thomas J. Polascik Brian T. Helfand Colette Hyatt Alicia K. Morgans Felix Y. Feng Michael P. Mullane Jacqueline Powers Raoul S. Concepcion Daniel W. Lin Richard C. Wender James Ryan Mark Anthony J. Costello Arthur L. Burnett Oliver Sartor William B. Isaacs Jianfeng Xu Jeffrey N. Weitzel Gerald L. Andriole Himisha Beltran Alberto Briganti Lindsey Byrne Anne Calvaresi Thenappan Chandrasekar David Y.T. Chen Robert B. Den Albert Dobi E. David Crawford James A. Eastham Scott E. Eggener Matthew L. Freedman Marc B. Garnick Patrick T. Gomella Nathan Handley Mark Hurwitz Joseph K. Izes R. Jeffrey Karnes Costas D. Lallas Lucia R. Languino Stacy Loeb Ana María López Kevin R. Loughlin Grace Lu‐Yao S. Bruce Malkowicz Mark Mann Patrick Mille Martin Miner Todd M. Morgan José Moreno Lorelei A. Mucci Ronald E. Myers Sarah M. Nielsen Brock O’Neil Wayne H. Pinover Peter A. Pinto Wendy Poage Ganesh V. Raj Timothy R. Rebbeck Charles J. Ryan Howard M. Sandler Matthew J. Schiewer Emily Scott Brittany M. Szymaniak William Tester Edouard J. Trabulsi Neha Vapiwala Evan Y. Yu Charnita Zeigler‐Johnson Leonard G. Gomella

Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary assessment. Critical needs include optimized multigene strategies that incorporate evolving genetic data, consistency in GT indications alternate evaluation models address the rising demand for services. A multidisciplinary consensus conference included experts, stakeholders, national organization leaders was convened response to current practice challenges develop implementation...

10.1200/jco.20.00046 article EN Journal of Clinical Oncology 2020-06-09

The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in implementation screening, biopsy, follow-up. This is Part I two-part series that focuses screening. Please refer II for discussion initial repeat biopsies as well biopsy technique. systematic review utilized inform this guideline was conducted by an independent methodological consultant. based searches Ovid MEDLINE Embase Cochrane...

10.1097/ju.0000000000003491 article EN The Journal of Urology 2023-04-25

The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in implementation screening, biopsy, follow-up. This is Part II two-part series focusing initial repeat biopsies, biopsy technique. Please refer I for discussion screening recommendations. systematic review utilized inform this guideline was conducted by an independent methodological consultant. based searches Ovid MEDLINE Embase...

10.1097/ju.0000000000003492 article EN The Journal of Urology 2023-04-25

• A significant proportion of men with erectile dysfunction (ED) exhibit early signs coronary artery disease (CAD), and this group may develop more severe CAD than without ED (Level 1, Grade A). The time interval among the onset symptoms occurrence cardiovascular events is estimated at 2–3 years 3–5 respectively; allows for risk factor reduction 2, B). associated increased all-cause mortality primarily due to All should undergo a thorough medical assessment, including testosterone, fasting...

10.1111/j.1742-1241.2010.02410.x article EN International Journal of Clinical Practice 2010-04-14

Measurements were made of parent and branch vessel diameters the included angles branch-points from postmortem human coronary arteriograms to determine usefulness theoretical equations predicting relationships between caliber arterial branch-angle. The formulas based on concept that blood size arrangement provided for flow with minimum energy loss. Size its branches determined 42 left main 53 other epicardial artery in hearts angiographically normal arteries. Left studied 68 various degrees...

10.1161/01.res.38.6.572 article EN Circulation Research 1976-06-01

Background: Most cardiovascular (CV)/stroke risk calculators using the integration of carotid ultrasound image-based phenotypes (CUSIP) with conventional factors (CRF) have shown improved stratification compared either method. However such approaches not yet leveraged potential machine learning (ML). intelligent ML strategies use follow-ups for endpoints but are costly and time-intensive. We introduce an integrated system stenosis as endpoint training determine whether a can lead to superior...

10.21037/cdt.2019.09.03 article EN Cardiovascular Diagnosis and Therapy 2019-10-01

Background: The previous COVID-19 lung diagnosis system lacks both scientific validation and the role of explainable artificial intelligence (AI) for understanding lesion localization. This study presents a cloud-based AI, “COVLIAS 2.0-cXAI” using four kinds class activation maps (CAM) models. Methodology: Our cohort consisted ~6000 CT slices from two sources (Croatia, 80 patients Italy, 15 control patients). COVLIAS 2.0-cXAI design three stages: (i) automated segmentation hybrid deep...

10.3390/diagnostics12061482 article EN cc-by Diagnostics 2022-06-16
Coming Soon ...